
Marianne P. Allen
Examiner (ID: 17617, Phone: (571)272-0712 , Office: P/1647 )
| Most Active Art Unit | 1647 |
| Art Unit(s) | 1818, 1812, 1645, 1805, 1631, 1647 |
| Total Applications | 2168 |
| Issued Applications | 1046 |
| Pending Applications | 251 |
| Abandoned Applications | 885 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 8152105
[patent_doc_number] => 08168591
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-05-01
[patent_title] => 'Compositions and methods related to anti-FGF agents'
[patent_app_type] => utility
[patent_app_number] => 11/582590
[patent_app_country] => US
[patent_app_date] => 2006-10-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 9959
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/168/08168591.pdf
[firstpage_image] =>[orig_patent_app_number] => 11582590
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/582590 | Compositions and methods related to anti-FGF agents | Oct 16, 2006 | Issued |
Array
(
[id] => 5237144
[patent_doc_number] => 20070129301
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-06-07
[patent_title] => 'METHODS AND COMPOSITIONS FOR MODULATING HGF/MET'
[patent_app_type] => utility
[patent_app_number] => 11/537753
[patent_app_country] => US
[patent_app_date] => 2006-10-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 29436
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0129/20070129301.pdf
[firstpage_image] =>[orig_patent_app_number] => 11537753
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/537753 | METHODS AND COMPOSITIONS FOR MODULATING HGF/MET | Oct 1, 2006 | Abandoned |
Array
(
[id] => 256206
[patent_doc_number] => 07575879
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-08-18
[patent_title] => 'Polypeptides homologous to VEGF and BMP1'
[patent_app_type] => utility
[patent_app_number] => 11/536590
[patent_app_country] => US
[patent_app_date] => 2006-09-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 14
[patent_no_of_words] => 38401
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/575/07575879.pdf
[firstpage_image] =>[orig_patent_app_number] => 11536590
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/536590 | Polypeptides homologous to VEGF and BMP1 | Sep 27, 2006 | Issued |
Array
(
[id] => 5220247
[patent_doc_number] => 20070161558
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-07-12
[patent_title] => 'Production of Vascular Endothelial Cell Growth Factor and DNA Encoding Same'
[patent_app_type] => utility
[patent_app_number] => 11/535976
[patent_app_country] => US
[patent_app_date] => 2006-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 14076
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0161/20070161558.pdf
[firstpage_image] =>[orig_patent_app_number] => 11535976
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/535976 | Production of Vascular Endothelial Cell Growth Factor and DNA Encoding Same | Sep 26, 2006 | Abandoned |
Array
(
[id] => 5126371
[patent_doc_number] => 20070238642
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-10-11
[patent_title] => 'Production of Vascular Endothelial Cell Growth Factor and DNA Encoding Same'
[patent_app_type] => utility
[patent_app_number] => 11/534619
[patent_app_country] => US
[patent_app_date] => 2006-09-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 14470
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0238/20070238642.pdf
[firstpage_image] =>[orig_patent_app_number] => 11534619
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/534619 | Production of Vascular Endothelial Cell Growth Factor and DNA Encoding Same | Sep 21, 2006 | Abandoned |
Array
(
[id] => 5446025
[patent_doc_number] => 20090047251
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-02-19
[patent_title] => 'Conjugates of hydroxyalkyl starch and a protein'
[patent_app_type] => utility
[patent_app_number] => 11/518558
[patent_app_country] => US
[patent_app_date] => 2006-09-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 45
[patent_figures_cnt] => 45
[patent_no_of_words] => 86969
[patent_no_of_claims] => 84
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0047/20090047251.pdf
[firstpage_image] =>[orig_patent_app_number] => 11518558
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/518558 | Conjugates of hydroxyalkyl starch and a protein | Sep 7, 2006 | Issued |
Array
(
[id] => 5182615
[patent_doc_number] => 20070053961
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-03-08
[patent_title] => 'Diagnostic markers of wound infection II'
[patent_app_type] => utility
[patent_app_number] => 11/516210
[patent_app_country] => US
[patent_app_date] => 2006-09-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 6151
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0053/20070053961.pdf
[firstpage_image] =>[orig_patent_app_number] => 11516210
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/516210 | Diagnostic markers of wound infection II | Sep 5, 2006 | Abandoned |
Array
(
[id] => 5538683
[patent_doc_number] => 20090220488
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-09-03
[patent_title] => 'EVALUATING AND TREATING SCLERODERMA'
[patent_app_type] => utility
[patent_app_number] => 12/065217
[patent_app_country] => US
[patent_app_date] => 2006-08-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17375
[patent_no_of_claims] => 54
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0220/20090220488.pdf
[firstpage_image] =>[orig_patent_app_number] => 12065217
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/065217 | EVALUATING AND TREATING SCLERODERMA | Aug 23, 2006 | Abandoned |
Array
(
[id] => 5040236
[patent_doc_number] => 20070092518
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-04-26
[patent_title] => 'Anti-TNFalpha antibodies and methods of use'
[patent_app_type] => utility
[patent_app_number] => 11/496129
[patent_app_country] => US
[patent_app_date] => 2006-07-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 5157
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0092/20070092518.pdf
[firstpage_image] =>[orig_patent_app_number] => 11496129
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/496129 | Anti-TNFα antibodies | Jul 30, 2006 | Issued |
Array
(
[id] => 5177467
[patent_doc_number] => 20070178527
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-08-02
[patent_title] => 'Human platelet-derived growth factor receptors'
[patent_app_type] => utility
[patent_app_number] => 11/495096
[patent_app_country] => US
[patent_app_date] => 2006-07-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 30629
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0178/20070178527.pdf
[firstpage_image] =>[orig_patent_app_number] => 11495096
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/495096 | Human platelet-derived growth factor receptors | Jul 27, 2006 | Abandoned |
Array
(
[id] => 4797410
[patent_doc_number] => 20080008996
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-01-10
[patent_title] => 'Nucleic acid molecules and other molecules associated with plants'
[patent_app_type] => utility
[patent_app_number] => 11/491371
[patent_app_country] => US
[patent_app_date] => 2006-07-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33634
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0008/20080008996.pdf
[firstpage_image] =>[orig_patent_app_number] => 11491371
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/491371 | Nucleic acid molecules and other molecules associated with plants | Jul 23, 2006 | Abandoned |
Array
(
[id] => 4909175
[patent_doc_number] => 20080019941
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-01-24
[patent_title] => 'Methods, systems and reagents for scar reduction'
[patent_app_type] => utility
[patent_app_number] => 11/490413
[patent_app_country] => US
[patent_app_date] => 2006-07-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4581
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0019/20080019941.pdf
[firstpage_image] =>[orig_patent_app_number] => 11490413
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/490413 | Methods, systems and reagents for scar reduction | Jul 19, 2006 | Abandoned |
Array
(
[id] => 220884
[patent_doc_number] => 07608430
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-10-27
[patent_title] => 'Interferon-γ antagonists and therapeutic uses thereof'
[patent_app_type] => utility
[patent_app_number] => 11/481614
[patent_app_country] => US
[patent_app_date] => 2006-07-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7416
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/608/07608430.pdf
[firstpage_image] =>[orig_patent_app_number] => 11481614
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/481614 | Interferon-γ antagonists and therapeutic uses thereof | Jul 5, 2006 | Issued |
Array
(
[id] => 4533708
[patent_doc_number] => 07871980
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-01-18
[patent_title] => 'Method of treating mouse carrying human hepatocytes'
[patent_app_type] => utility
[patent_app_number] => 11/988028
[patent_app_country] => US
[patent_app_date] => 2006-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 5796
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/871/07871980.pdf
[firstpage_image] =>[orig_patent_app_number] => 11988028
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/988028 | Method of treating mouse carrying human hepatocytes | Jun 29, 2006 | Issued |
Array
(
[id] => 228879
[patent_doc_number] => 07601692
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-10-13
[patent_title] => 'MCP-1 splice variants and methods of using same'
[patent_app_type] => utility
[patent_app_number] => 11/471652
[patent_app_country] => US
[patent_app_date] => 2006-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 12
[patent_no_of_words] => 28026
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/601/07601692.pdf
[firstpage_image] =>[orig_patent_app_number] => 11471652
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/471652 | MCP-1 splice variants and methods of using same | Jun 20, 2006 | Issued |
Array
(
[id] => 91731
[patent_doc_number] => 07732167
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-06-08
[patent_title] => 'Interferon-α/β binding fusion proteins and therapeutic uses thereof'
[patent_app_type] => utility
[patent_app_number] => 11/453530
[patent_app_country] => US
[patent_app_date] => 2006-06-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7332
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/732/07732167.pdf
[firstpage_image] =>[orig_patent_app_number] => 11453530
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/453530 | Interferon-α/β binding fusion proteins and therapeutic uses thereof | Jun 14, 2006 | Issued |
Array
(
[id] => 8283051
[patent_doc_number] => 08217152
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-07-10
[patent_title] => 'Process for the purification of IL-18 binding protein'
[patent_app_type] => utility
[patent_app_number] => 11/916087
[patent_app_country] => US
[patent_app_date] => 2006-06-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 11302
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11916087
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/916087 | Process for the purification of IL-18 binding protein | Jun 7, 2006 | Issued |
Array
(
[id] => 5125880
[patent_doc_number] => 20070238151
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-10-11
[patent_title] => 'Novel compounds'
[patent_app_type] => utility
[patent_app_number] => 11/445001
[patent_app_country] => US
[patent_app_date] => 2006-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 74238
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0238/20070238151.pdf
[firstpage_image] =>[orig_patent_app_number] => 11445001
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/445001 | Novel compounds | May 31, 2006 | Abandoned |
Array
(
[id] => 5119948
[patent_doc_number] => 20070141662
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-06-21
[patent_title] => 'Fusion proteins and methods of cleavage of such proteins'
[patent_app_type] => utility
[patent_app_number] => 11/439896
[patent_app_country] => US
[patent_app_date] => 2006-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4953
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0141/20070141662.pdf
[firstpage_image] =>[orig_patent_app_number] => 11439896
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/439896 | Fusion proteins and methods of cleavage of such proteins | May 23, 2006 | Abandoned |
Array
(
[id] => 5095496
[patent_doc_number] => 20070117105
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-05-24
[patent_title] => 'Interferon assay'
[patent_app_type] => utility
[patent_app_number] => 11/431775
[patent_app_country] => US
[patent_app_date] => 2006-05-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 15363
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0117/20070117105.pdf
[firstpage_image] =>[orig_patent_app_number] => 11431775
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/431775 | Interferon assay | May 8, 2006 | Abandoned |